Ischemic dilated cardiomyopathy pathophysiology through microRNA-16-5p
Ischemic dilated cardiomyopathy pathophysiology through microRNA-16-5p
复制标题
DOI:
10.1016/j.rec.2020.08.012
复制
发表时间:
2021-09-01
影响因子:
5.9
通讯作者:
Toro, Rocio
中科院分区:
文献类型:
--
作者:
Calderon-Dominguez, Maria;Mangas, Alipio;Toro, Rocio
Introduction and objectives The expression levels of microRNA-16-5p (miR-16) are upregulated in ischemic cardiomyopathy and in animal models of ischemic dilated cardiomyopathy (iDCM), inducing myocardial apoptosis. We investigated the role of miR-16 in the adaptive cellular response associated with endoplasmic reticulum (ER) stress and autophagy in the apoptotic iDCM environment.Methods: We quantified the miR-16 plasma levels of 168 participants-76 controls, 60 iDCM patients, and 32 familial DCM patients with the pathogenic variant of BAG3-by quantitative real-time polymerase chain reaction and correlated the levels with patient variables. The effects of intracellular miR-16 overexpression were analyzed in a human cardiac cell line. Apoptosis and cell viability were measured, as well as the levels of markers associated with ER stress, cardiac injury, and autophagy.Results: Plasma miR-16 levels were upregulated in iDCM patients (P = .039). A multivariate logistic regression model determined the association of miR-16 with iDCM clinical variables (P < .001). In vitro, miR-16 overexpression increased apoptosis (P = .02) and reduced cell viability (P = .008). Furthermore, it induced proapoptotic components of ER stress, based on upregulation of the PERK/CHOP pathway. However, we observed augmentation of autophagic flux (P < .001) without lysosomal blockade by miR16 as a possible cytoprotective mechanism.Conclusion: MiR-16 is specifically associated with iDCM. In an ischemic setting, miR-16 activates ER stress and promotes inflammation followed by autophagy in human cardiac cells. Thus, autophagy may be an attempt to maintain cellular homeostasis in response to misfolded/aggregated proteins related to ER stress, prior to apoptosis. (C) 2020 Sociedad Espanola de Cardiologfa. Published by Elsevier Espana, S.L.U. All rights reserved.